MedPath

Comparison of two different forms of chlorhexidine solution for skin antisepsis in neonates

Not Applicable
Completed
Registration Number
CTRI/2019/06/019822
Lead Sponsor
All India Instiute of Medical Sciences AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
685
Inclusion Criteria

1) All inborn neonates from 26 0/7 - 42 6/7 weeks of gestation requiring NICU admission for at least 48 hrs

2) All extramural neonates from 26 0/7 - 42 6/7 weeks of gestation requiring admission in PICU/Pediatric surgery ICU/Pediatric HDU/Pediatric emergency irrespective of the duration of stay

Exclusion Criteria

1) Hydrops

2) Generalised skin disorder

3) Skin infection

4) Severe persistent pulmonary hypertension

5) Sick baby requiring high ventilator support as adjudged by the clinical team

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the proportion of negative post cleansing skin swabs after the skin antisepsis performed by 1% aqueous chlorhexidine gluconate v/s 2 % aqueous chlorhexidine gluconate in neonates 26 0/7-42 6/7 weeks of gestation in first 28 days of lifeTimepoint: post antisepsis skin swab will be taken after 2 minutes of chlorhexidine application
Secondary Outcome Measures
NameTimeMethod
Chlorhexidine level estimation in a subset of patientsTimepoint: at 6,12,24-48 hours after chlorhexidine application;To compare local skin reaction to chlorhexidine gluconate applicationTimepoint: At 0,6,12,24 hours after chlorhexidine application
© Copyright 2025. All Rights Reserved by MedPath